Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-29

Clinical Trial Update: Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluated intensity-modulated radiation therapy with cisplatin for stage I–IVA cervical cancer, with results now posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)

Snippet

Sponsor: University of California, San Diego | Conditions: Cervical Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-11-29